Keywords: Novartis, Pennsylvania University, Collaboration, Academia, Cancer treatments, R&D facility, CART-19, Leukemia

Novartis in deal with Penn University to advance cancer treatments

Article | 08 August 2012

Print This

In yet another Pharma move to link up with academia, Swiss drug major Novartis (NOVN: VX) this week announced it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in